Athira Pharma, Inc. (ATHA) Reports In-Line Q2 EPS

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.78), in-line with the analyst estimate of ($0.78).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Evommune, Inc. (EVMN) Misses Q2 EPS by 20c
• Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c